Estimating locus heterogeneity in autosomal dominant polycystic kidney disease (ADPKD) 26 families the disease resulted from PKD1 mutations, whereas in three families it resulted from mutations in a locus other than PKD1. The two other families were not informative. Using the HOMOG test, the incidence of the PKD1 linked mutations in Spain is 85%. Multipoint linkage analysis in the 26 PKD1 families showed that the disease locus lies in the interval between D16S259(pGGG1) and D16S125(26.6). (J Med Genet 1993; 30:910-13) Autosomal dominant polycystic kidney disease (ADPKD1) is one of the most frequent inherited monogenic disorders, affecting 1 per 1000 of the European population. It is characterised by the formation and progressive enlargement of cysts The maximum multipoint lod score under heterogeneity in the first test (Z=21 47) was obtained by placing PKD 1 2 cM proximal to D16S259 and 1 cM distal to D16S125. In the second test the maximum lod score (Z = 22-28) was obtained with the disease locus 1-5 cM proximal to D16S259 and 1 5 cM distal to D16S125 (table 3) . These estimates are consistent with previous studies that placed PKD1 between these loci.8 In the figure, lod scores obtained in multipoint analysis are plotted using a fixed map of three markers (test 2 in table 3) under the assumptions of heterogeneity (a= 085) or homogeneity (a= 1), taking the position of D16S259 (pGGG1) as point 0.
Three families out of 31 analysed show statistically significant evidence of non-linkage to PKD1 (table 4), with probabilities of 0 012 (6002), 0 021 (6008), and 0-000 (6030) that they are linked to PKD1. Two families were considered not to be informative since they have probabilities of linkage of 0 734 (6001) and 0-729 (6054), with approximate 95% confidence limits of 0-228-0904 and 0 410-0 909, respectively. All data supported PKD1 being the locus causing the disease in the remaining 26 families (conditional probability of linkage higher than 0 9 in each case). As expected, the maximum two point lod scores between the disease and chromosome 16 markers increased when they were claculated for this group of families (compare A and B in table 2). The only exception is D16S246, which is because Peral, San Millan, Hernandez, Valero, Lathrop, Beckmann, Moreno Table 2 Maximum two point lod scores for linkage between ADPKD and chromosome 16 marker loci. this marker was not informative in the families unlinked to PKD1. Eight recombination events between marker loci and PKD 1 were detected. In five cases the subject giving rise to the crossover was a male and in three cases a female. In each case at least one informative flanking marker confirmed the crossover with the disease. Six of these recombination events were observed on the distal side of PKD1, four between D16S85 and PKD1, one between D16S21 and PKD1, and one between D16S259 and PKD1. On the proximal side two recombination events were observed, both between D16S246 and PKDl.
One crossover involving a normal and a disease bearing chromosome 16 occurred between D16S259 and D16S125 but, as the subject was too young to express the disease, it was impossible to predict whether the recombination site was proximal or distal to PKD1. No evidence for linkage disequilibrium between any allele of the six marker loci and PKD 1 was obtained.
A mutation causing the disease in a Danish family has been suggested to be linked to locus D2S44 on the short arm of chromosome 2 (lod score 2 12 at a recombination fraction of 0 10),13 so we characterised our three 'unlinked' families for the same polymorphism (a PvuII VNTR at locus D2S44). In the three cases negative lod scores for linkage of the disease and D2S44 were obtained (data not shown).
Discussion
The results presented in this study provide evidence for genetic heterogeneity of ADPKD in the Spanish population. Two tests, based on multipoint analysis, were significant with likelihood ratios in favour of heterogeneity of over Given the locus heterogeneity of the disease, it is essential for genetic predictive diagnosis to show linkage between the disease and reference markers near the PKD 1 gene in each family. However, several potential pitfalls exist which can lead to a misleading genetic assignment. Apart from genetic heterogeneity, false negative and false positive diagnoses, double recombinants, gene conversion events, mistyping, or non-paternity can lead to erroneous interpretation of results, so it is important to accumulate as much genetic evidence as possible for the distinction between 'linked' and 'unlinked' families to be made. Different authors have shown that, compared with PKD 1, non-PKD 1 families have a milder phenotypic expression of the disease,'52021 and that selection of families through renal clinics is likely to have led to underestimation of the prevalence of non-PKD 1.2' In our study, 70% of the families were ascertained by renal clinics and two of the three non-PKD 1 probands belong to this group (although they started dialysis at a late age: 63 and 66 years old, respectively).
Previous physical and genetic studies have shown that the PKD1 locus lies in the region between D16S259 (pGGG1) and D16S125 (26.6), a 750 kb CpG rich region. 
